PUBLISHER: KBV Research | PRODUCT CODE: 1276828
PUBLISHER: KBV Research | PRODUCT CODE: 1276828
The Europe Diabetic Socks Market would witness market growth of 5.5% CAGR during the forecast period (2023-2029).
Many firms have entered the market with a unique product offering to draw in many clients, spurred on by the strong demand for diabetic socks among consumers. To anticipate potential foot injuries, these socks feature neuro-fabric technology, enabling them to monitor foot temperatures. To decrease temperature, irritation, redness, blisters, or fungus, manufacturers have also been concentrating on how pleasant the socks are. They use neuro fabric material or gel padding material. Additionally, they are chargeless and machine washable.
Other crucial features that many manufacturers have included are moisture-wicking materials that keep the foot dry so that additional moisture is not used as a breeding ground for fungi illnesses and antibacterial ingredients in the fabric. In addition, additional padding for susceptible areas, including the soles of the feet, has improved these fabrics and helps prevent foot damage. Usually, these socks are seamless and non-elastic. For those who have diabetes, diabetic socks are a crucial preventive measure since they work to shield the feet from harm.
In Europe, diabetes is growing more prevalent among people of all ages as a result of rising rates of overweight and obesity, a bad diet, and insufficient exercise. 60 million people in the European region have diabetes, which represents 10.3% of men and 9.6% of women who are 25 years of age or older. Furthermore, diabetes has been detected in 15.3% of Germans, according to the International Diabetes Federation (IDF). According to the group, this represents a 25% rise from the rate (12.2%) from the prior year. About 9.5 million adults in Germany are thought to have diabetes, which puts them at risk for complications that could be fatal. The requirement for preventive treatment comes as a result of the rising prevalence of diabetes, which is further associated with the risk of diabetic neuropathy, diabetic ulcer, and others. The regional market for diabetic socks is predicted to benefit from this.
The Germany market dominated the Europe Diabetic Socks Market by Country in 2022; thereby, achieving a market value of $31.2 million by 2029. The UK market is poised to grow at a CAGR of 4.6% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 6.3% during (2023 - 2029).
Based on Distribution Channel, the market is segmented into Offline and Online. Based on Type, the market is segmented into Calf Length, Knee Length and Ankle Length. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Enovis Corporation, I-Runner (Healer Health LLC), Orthofeet, Inc., Knit-Rite, LLC, Drew Shoe Corporation, Creswell Sock Mills, HJ Sock Group Ltd. (Pantherella International Group Ltd), Syounaa (Nishikaa Garments International LLP), and Simcan Enterprises Inc.
Market Segments covered in the Report:
By Distribution Channel
By Type
By Country
Companies Profiled
Unique Offerings from KBV Research
List of Figures